Clinical Trial Update: Clinical Study of 18F-Alfatide Injection PET/CT [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates an ongoing study of the PET/CT tracer 18F-Alfatide for non-small cell lung cancer, currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 18F-Alfatide

Snippet

Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD. | Conditions: Non-Small Cell Lung Cancer NSCLC | Phase 3 | Status: NOT_YET_RECRUITING